The findings identify TSPAN3 as a marker of a previously unrecognized secretory MVB population distinguished by its intracellular trafficking, molecular interactions, and EV composition, supporting a model in which distinct tetraspanin-organized membrane nanodomains are associated with different intracellular trafficking routes and molecularly distinct EV populations.
Abstract
Extracellular vesicles (EVs) comprise molecularly diverse populations generated through multiple membrane-trafficking pathways, yet the intracellular basis of this heterogeneity remains poorly understood. Here, we identify the EV-associated tetraspanin TSPAN3 as a marker of a secretory multivesicular body (MVB) population that is molecularly and functionally distinct from canonical CD63-positive compartments. Using endogenous genome editing, live-cell and super-resolution microscopy, electron microscopy, quantitative EV secretion assays, and complementary proteomic approaches, we show that TSPAN3 localizes to fusion-competent MVBs but exhibits limited overlap with CD63 during secretion. Unlike CD63, which extensively traffics through the plasma membrane and depends on YXXΦ-mediated endocytic retrieval, TSPAN3 reaches secretory MVBs predominantly through an intracellular trafficking route that relies on a dileucine-containing sorting region. Orthogonal proximity-labeling and affinity-purification proteomics revealed that TSPAN3-positive compartments are associated with a selective LC3/ATG8-related membrane network, including GABARAPL2 and proteins involved in endosomal membrane remodeling and fusion. Perturbation of residues required for this association impaired localization to LC3-positive compartments and reduced secretory MVB fusion. Consistent with these findings, pharmacological disruption of autophagy-and endolysosomal-associated pathways differentially altered TSPAN3-positive EV secretion. Finally, proximity-labeled EV proteomics demonstrated that TSPAN3-associated EVs possess cargo signatures distinct from CD63-associated EVs, with greater representation of endosomal and endolysosomal proteins suggesting that tetraspanin-associated membrane nanodomains retain molecular signatures consistent with their intracellular trafficking history. Together, our findings identify TSPAN3 as a marker of a previously unrecognized secretory MVB population distinguished by its intracellular trafficking, molecular interactions, and EV composition, supporting a model in which distinct tetraspanin-organized membrane nanodomains are associated with different intracellular trafficking routes and molecularly distinct EV populations.
Multivesicular endosome (MVE) fusion with the plasma membrane is a key step in the release of small extracellular vesicles (sEVs), including exosomes, which mediate intercellular communication and contribute to disease processes. Lipid signaling has been implicated in regulating membrane fusion, with phospholipase D (P...
Vesicular membrane trafficking is central to eukaryotic homeostasis, governing receptor downregulation, lysosomal degradation, and intercellular communication via exosomes. These processes are classically explained by SNARE-mediated fusion and ESCRT-dependent membrane remodeling, which together define current models of...
Mohammed A. Abdel-Rasol, W. El-Sayed· Cell Communication and Signa...· 0 citations
A previously unrecognized role for TFEB is uncovered in controlling the lipid composition and membrane fluidity of multivesicular bodies, establishing endosomal membrane properties as a regulated output of transcriptional programs that govern cargo trafficking and cell behavior.
Julie Patat, Aline Mathey, E. Ouni et al.· bioRxiv· 0 citations
Findings show that P. nicotianae secretes structurally heterogeneous EV-like particles with biological activity in plant and bacterial assays, and suggest potential roles in host interaction, microbial competition, and putative conserved features that may be involved in cargo loading.
C. I. Nxumalo, B. C. Salasini, S. Maphosa et al.· Frontiers in Plant Science· 0 citations
This Review provides a framework for selecting disease-matched degradation routes and advancing meTPDs from platform-specific demonstrations towards predictable therapeutic modalities by integrating molecular design, receptor biology, intracellular trafficking, delivery and pharmacodynamic considerations.
Shu-Tong Lin, Hui-Ling Zhou, Jia-Yan Qiu et al.· Advanced Drug Delivery Revie...· 0 citations